Case report shows partial tumor regression in a young man with malignant solitary fibrous tumor after therapy, indicating potential treatment efficacy.
Solitary fibrous tumor (SFT) is a mesenchymal tumor with unpredictable biological behavior that can occur in multiple anatomic sites throughout the body. This case report describes a 22-year-old man with an intracranial malignant solitary fibrous tumor. After 3 courses of 177Lu-FAP-2286 therapy, 68Ga-FAP-2286 PET/CT revealed partial tumor regression, with the patient reporting no adverse reactions.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: